Fas-ligand expression by human trophoblasts: Implications for fetal survival and immune privilege.

被引：0
|
作者：
Balkundi, D [1 ]
Hanna, N [1 ]
Dougherty, J [1 ]
Sharma, S [1 ]
机构：
[1] Brown Univ, Women & Infants Hosp, Dept Pediat, Providence, RI 02912 USA
来源：
JOURNAL OF INVESTIGATIVE MEDICINE | 1999年 / 47卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：176A / 176A
页数：1
相关论文
共 50 条
  • [21] Fas ligand expression by astrocytoma in vivo: Maintaining immune privilege in the brain?
    Saas, P
    Walker, PR
    Hahne, M
    Quiquerez, AL
    Schnuriger, V
    Perrin, G
    French, L
    Van Meir, EG
    deTribolet, N
    Tschopp, J
    Dietrich, PY
    JOURNAL OF CLINICAL INVESTIGATION, 1997, 99 (06): : 1173 - 1178
  • [22] In vivo expression of fas and fas-ligand in uveal melanoma.
    Boeloeni, R
    Stang, A
    Coupland, SE
    Schilling, H
    Bornfeld, N
    Anastassiou, C
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2000, 41 (04) : S382 - S382
  • [23] Expression of Fas-ligand in first trimester and term human placental villi
    Hammer, A
    Dohr, G
    JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 2000, 46 (02) : 83 - 90
  • [24] Exogenous expression of fas-ligand or CrmA prolongs the survival in rat liver transplantation
    Adachi, K.
    Fujino, M.
    Kitazawa, Y.
    Funeshima-Fuji, N.
    Takahara, S.
    Kimura, H.
    Li, X. -K.
    TRANSPLANTATION PROCEEDINGS, 2006, 38 (08) : 2710 - 2713
  • [25] Overexpression of Fas-ligand in human nasal polyps
    Fang, SY
    Yang, BC
    ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY, 2000, 109 (03): : 267 - 270
  • [26] The role of placental Fas ligand in maintaining immune privilege at maternal-fetal interfaces
    Guller, S
    LaChapelle, L
    SEMINARS IN REPRODUCTIVE ENDOCRINOLOGY, 1999, 17 (01): : 39 - 44
  • [27] Expression of Fas (CD95) and Fas-ligand in normal and tumorous human thyroid tissues
    Fantus, D
    Ezzat, S
    Asa, SL
    MODERN PATHOLOGY, 1998, 11 (01) : 56A - 56A
  • [28] Regulation of Fas and Fas-ligand expression in NK cells by cytokines and the involvement of Fas-ligand in NK/LAK cell-mediated cytotoxicity
    Medvedev, AE
    Johnsen, AC
    Haux, J
    Steinkjer, B
    Egeberg, K
    Lynch, DH
    Sundan, A
    Espevik, T
    CYTOKINE, 1997, 9 (06) : 394 - 404
  • [29] Fas ligand mediates immune privilege and not inflammation in human colon cancer, irrespective of TGF-β expression
    Houston, A
    Bennett, MW
    O'Sullivan, GC
    Shanahan, F
    O'Connell, J
    BRITISH JOURNAL OF CANCER, 2003, 89 (07) : 1345 - 1351
  • [30] Fas ligand mediates immune privilege and not inflammation in human colon cancer, irrespective of TGF-β expression
    A Houston
    M W Bennett
    G C O'Sullivan
    F Shanahan
    J O'Connell
    British Journal of Cancer, 2003, 89 : 1345 - 1351
12345